In colorectal cancer, IL-22-producing infiltrating CD4 + and CD8 + T-cells were correlated with a better clinical outcome and increased infiltration of neutrophils, which in turn enhanced anti-tumor T-cell responses58. This evidence concerns the gene IL22 and neoplasm.